Portal:CPTAC/Hallmark/Proliferative

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(added pw titles)
Current revision (00:11, 11 October 2019) (view source)
(removed main pathway models)
 
(13 intermediate revisions not shown.)
Line 1: Line 1:
 +
The normal control of cell growth and division in cells is governed by careful control and release of growth-promoting signals, but in cancer cells this control is deregulated.
 +
Signaling through growth factors via the tyrosine kinase domains of cell-surface receptors, trigger progression through the cell cycle and other pathways. (Adapted from [https://www.ncbi.nlm.nih.gov/pubmed/21376230 Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011])
*[[Pathway:WP3972]] PDGFR-beta pathway
*[[Pathway:WP3972]] PDGFR-beta pathway
*[[Pathway:WP673]] ErbB Signaling Pathway
*[[Pathway:WP673]] ErbB Signaling Pathway
*[[Pathway:WP581]] EPO Receptor Signaling
*[[Pathway:WP581]] EPO Receptor Signaling
*[[Pathway:WP382]] MAPK Signaling Pathway
*[[Pathway:WP382]] MAPK Signaling Pathway
 +
*[[Pathway:WP4223]] Ras Signaling
 +
*[[Pathway:WP4205]] MET in type 1 papillary renal cell carcinoma
 +
*[[Pathway:WP313]] Signaling of Hepatocyte Growth Factor Receptor
 +
*[[Pathway:WP4553]] FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma
 +
*[[Pathway:WP4566]] Translation inhibitors in chronically activated PDGFRA cells
 +
*[[Pathway:WP4541]] Hippo-Merlin Signaling Dysregulation

Current revision

The normal control of cell growth and division in cells is governed by careful control and release of growth-promoting signals, but in cancer cells this control is deregulated. Signaling through growth factors via the tyrosine kinase domains of cell-surface receptors, trigger progression through the cell cycle and other pathways. (Adapted from Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011)

Personal tools